121 related articles for article (PubMed ID: 30999060)
1. The olfactory bulb proteotype differs across frontotemporal dementia spectrum.
Lachén-Montes M; González-Morales A; Schvartz D; Zelaya MV; Ausin K; Fernández-Irigoyen J; Sánchez JC; Santamaría E
J Proteomics; 2019 Jun; 201():37-47. PubMed ID: 30999060
[TBL] [Abstract][Full Text] [Related]
2. Olfactory bulb proteome dynamics during the progression of sporadic Alzheimer's disease: identification of common and distinct olfactory targets across Alzheimer-related co-pathologies.
Zelaya MV; Pérez-Valderrama E; de Morentin XM; Tuñon T; Ferrer I; Luquin MR; Fernandez-Irigoyen J; Santamaría E
Oncotarget; 2015 Nov; 6(37):39437-56. PubMed ID: 26517091
[TBL] [Abstract][Full Text] [Related]
3. Tackling the Biological Meaning of the Human Olfactory Bulb Dyshomeostatic Proteome across Neurological Disorders: An Integrative Bioinformatic Approach.
Cartas-Cejudo P; Lachén-Montes M; Fernández-Irigoyen J; Santamaría E
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768771
[TBL] [Abstract][Full Text] [Related]
4. Olfactory bulb neuroproteomics reveals a chronological perturbation of survival routes and a disruption of prohibitin complex during Alzheimer's disease progression.
Lachén-Montes M; González-Morales A; Zelaya MV; Pérez-Valderrama E; Ausín K; Ferrer I; Fernández-Irigoyen J; Santamaría E
Sci Rep; 2017 Aug; 7(1):9115. PubMed ID: 28831118
[TBL] [Abstract][Full Text] [Related]
5. Amyotrophic Lateral Sclerosis Is Accompanied by Protein Derangements in the Olfactory Bulb-Tract Axis.
Lachén-Montes M; Mendizuri N; Ausin K; Andrés-Benito P; Ferrer I; Fernández-Irigoyen J; Santamaría E
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167591
[TBL] [Abstract][Full Text] [Related]
6. An early dysregulation of FAK and MEK/ERK signaling pathways precedes the β-amyloid deposition in the olfactory bulb of APP/PS1 mouse model of Alzheimer's disease.
Lachén-Montes M; González-Morales A; de Morentin XM; Pérez-Valderrama E; Ausín K; Zelaya MV; Serna A; Aso E; Ferrer I; Fernández-Irigoyen J; Santamaría E
J Proteomics; 2016 Oct; 148():149-58. PubMed ID: 27498392
[TBL] [Abstract][Full Text] [Related]
7. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
[TBL] [Abstract][Full Text] [Related]
8. Survival in progressive supranuclear palsy and frontotemporal dementia.
Chiu WZ; Kaat LD; Seelaar H; Rosso SM; Boon AJ; Kamphorst W; van Swieten JC
J Neurol Neurosurg Psychiatry; 2010 Apr; 81(4):441-5. PubMed ID: 20360166
[TBL] [Abstract][Full Text] [Related]
9. The frontal assessment battery is not useful to discriminate progressive supranuclear palsy from frontotemporal dementias.
Stamelou M; Diehl-Schmid J; Hapfelmeier A; Kontaxopoulou D; Stefanis L; Oertel WH; Bhatia KP; Papageorgiou SG; Höglinger GU
Parkinsonism Relat Disord; 2015 Oct; 21(10):1264-8. PubMed ID: 26324212
[TBL] [Abstract][Full Text] [Related]
10. Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders.
Mundiñano IC; Caballero MC; Ordóñez C; Hernandez M; DiCaudo C; Marcilla I; Erro ME; Tuñon MT; Luquin MR
Acta Neuropathol; 2011 Jul; 122(1):61-74. PubMed ID: 21553300
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.
Josephs KA; Petersen RC; Knopman DS; Boeve BF; Whitwell JL; Duffy JR; Parisi JE; Dickson DW
Neurology; 2006 Jan; 66(1):41-8. PubMed ID: 16401843
[TBL] [Abstract][Full Text] [Related]
12. PSP-FTD Complex: A Possible Variant of PSP.
Pradhan S; Tandon R
Am J Alzheimers Dis Other Demen; 2020; 35():1533317520922383. PubMed ID: 32648477
[TBL] [Abstract][Full Text] [Related]
13. Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia.
Yokoyama JS; Karch CM; Fan CC; Bonham LW; Kouri N; Ross OA; Rademakers R; Kim J; Wang Y; Höglinger GU; Müller U; Ferrari R; Hardy J; ; Momeni P; Sugrue LP; Hess CP; James Barkovich A; Boxer AL; Seeley WW; Rabinovici GD; Rosen HJ; Miller BL; Schmansky NJ; Fischl B; Hyman BT; Dickson DW; Schellenberg GD; Andreassen OA; Dale AM; Desikan RS
Acta Neuropathol; 2017 May; 133(5):825-837. PubMed ID: 28271184
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.
Abu-Rumeileh S; Mometto N; Bartoletti-Stella A; Polischi B; Oppi F; Poda R; Stanzani-Maserati M; Cortelli P; Liguori R; Capellari S; Parchi P
J Alzheimers Dis; 2018; 66(2):551-563. PubMed ID: 30320576
[TBL] [Abstract][Full Text] [Related]
15. Progressive supranuclear palsy in a family with TDP-43 pathology.
Kertesz A; Finger E; Murrell J; Chertkow H; Ang LC; Baker M; Ravenscroft T; Rademakers R; Munoz DG
Neurocase; 2015; 21(2):178-84. PubMed ID: 24479957
[TBL] [Abstract][Full Text] [Related]
16. Progressive modulation of the human olfactory bulb transcriptome during Alzheimer´s disease evolution: novel insights into the olfactory signaling across proteinopathies.
Lachen-Montes M; Zelaya MV; Segura V; Fernández-Irigoyen J; Santamaría E
Oncotarget; 2017 Sep; 8(41):69663-69679. PubMed ID: 29050232
[TBL] [Abstract][Full Text] [Related]
17. MRI signatures of the frontotemporal lobar degeneration continuum.
Agosta F; Galantucci S; Magnani G; Marcone A; Martinelli D; Antonietta Volontè M; Riva N; Iannaccone S; Ferraro PM; Caso F; Chiò A; Comi G; Falini A; Filippi M
Hum Brain Mapp; 2015 Jul; 36(7):2602-14. PubMed ID: 25821176
[TBL] [Abstract][Full Text] [Related]
18. Neuropathologic, biochemical, and molecular characterization of the frontotemporal dementias.
Mott RT; Dickson DW; Trojanowski JQ; Zhukareva V; Lee VM; Forman M; Van Deerlin V; Ervin JF; Wang DS; Schmechel DE; Hulette CM
J Neuropathol Exp Neurol; 2005 May; 64(5):420-8. PubMed ID: 15892300
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein D Upregulation in Alzheimer's Disease but Not Frontotemporal Dementia.
Bhatia S; Kim WS; Shepherd CE; Halliday GM
J Mol Neurosci; 2019 Jan; 67(1):125-132. PubMed ID: 30467822
[TBL] [Abstract][Full Text] [Related]
20. Distinct Pattern of Microgliosis in the Olfactory Bulb of Neurodegenerative Proteinopathies.
Kohl Z; Schlachetzki JC; Feldewerth J; Hornauer P; Münch M; Adame A; Riemenschneider MJ; Winkler J; Masliah E
Neural Plast; 2017; 2017():3851262. PubMed ID: 28409032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
